ATE43605T1 - Lipoloeslicher platin(ii)-komplex und dessen herstellung. - Google Patents

Lipoloeslicher platin(ii)-komplex und dessen herstellung.

Info

Publication number
ATE43605T1
ATE43605T1 AT86102860T AT86102860T ATE43605T1 AT E43605 T1 ATE43605 T1 AT E43605T1 AT 86102860 T AT86102860 T AT 86102860T AT 86102860 T AT86102860 T AT 86102860T AT E43605 T1 ATE43605 T1 AT E43605T1
Authority
AT
Austria
Prior art keywords
platinum
derivatives
complex
fatty acid
ammine
Prior art date
Application number
AT86102860T
Other languages
German (de)
English (en)
Inventor
Mitsuaki Maeda
Takuma Sasaki
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12675703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE43605(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Application granted granted Critical
Publication of ATE43605T1 publication Critical patent/ATE43605T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT86102860T 1985-03-06 1986-03-05 Lipoloeslicher platin(ii)-komplex und dessen herstellung. ATE43605T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4386985 1985-03-06
EP86102860A EP0193936B1 (en) 1985-03-06 1986-03-05 Liposoluble platinum (ii) complex and preparation thereof

Publications (1)

Publication Number Publication Date
ATE43605T1 true ATE43605T1 (de) 1989-06-15

Family

ID=12675703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86102860T ATE43605T1 (de) 1985-03-06 1986-03-05 Lipoloeslicher platin(ii)-komplex und dessen herstellung.

Country Status (8)

Country Link
US (1) US6613799B1 (enExample)
EP (1) EP0193936B1 (enExample)
JP (1) JPS6296A (enExample)
AT (1) ATE43605T1 (enExample)
AU (1) AU587235B2 (enExample)
CA (1) CA1261864A (enExample)
DE (1) DE3663667D1 (enExample)
ES (1) ES8704505A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
GB8620917D0 (en) * 1986-08-29 1986-10-08 Davidson B C Platinum derivatives & cancer treatments
US5011959A (en) * 1986-11-17 1991-04-30 The Board Of Regents, The University Of Texas System 1,2-diaminocyclohexane-platinum complexes with antitumor activity
US4880832A (en) * 1987-03-06 1989-11-14 Sumitomo Pharmaceuticals Company, Ltd. Liposoluble platinum (II) complex and preparation thereof
AU592927B2 (en) * 1988-02-18 1990-01-25 Sumitomo Pharmaceuticals Company, Limited Liposoluble platinum (ii) complex and preparation thereof
CA1339034C (en) * 1988-08-22 1997-04-01 Paul A. Tremblay Platinum complexes of single isomer neoalkyl acids
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
ES2097085B1 (es) * 1994-06-30 1997-11-16 Univ Salamanca Nuevos complejos de coordinacion de metales de transicion con actividad citostatica.
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
JP5096657B2 (ja) 2000-08-11 2012-12-12 大日本住友製薬株式会社 シスプラチン耐性癌治療剤
AUPR644301A0 (en) * 2001-07-17 2001-08-09 Unisearch Limited Method and composition for treatment of cancer
WO2005023824A2 (en) * 2003-08-13 2005-03-17 University Of South Florida Methods for inhibiting tumor cell proliferation
ITMI20052449A1 (it) * 2005-12-22 2007-06-23 Cell Therapeutics Europe Srl Nuovi bis-platino complessi ad attivita' antitumorale
CN101402655B (zh) * 2008-11-07 2011-06-15 江苏奥赛康药业有限公司 一种米铂的制备方法
CN101830933B (zh) * 2010-05-28 2012-07-25 昆明贵研药业有限公司 一种合成抗肿瘤药物米铂的方法
CN101899067A (zh) * 2010-08-10 2010-12-01 东南大学 米铂的制备方法
CN102516311B (zh) * 2011-11-03 2014-05-28 南京优科生物医药有限公司 一种米铂的制备方法
CN103570766B (zh) * 2012-08-09 2016-04-13 浙江海昶生物医药技术有限公司 一种新型铂类脂质体制剂及其制备方法
JP2016531112A (ja) * 2013-07-25 2016-10-06 ネムコア メディカル イノベーションズ インコーポレイテッド 疎水性白金誘導体のナノエマルジョン
CN103910762A (zh) * 2014-04-16 2014-07-09 北京美迪康信医药科技有限公司 一种米铂的制备方法
WO2015166498A1 (en) * 2014-05-02 2015-11-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Pt (iv) derivatives and nanocarriers comprising them
CN104211734A (zh) * 2014-08-10 2014-12-17 昆明贵研药业有限公司 一种合成抗肿瘤药物庚铂的新方法
CN105153238B (zh) * 2015-09-12 2017-08-15 山东罗欣药业集团股份有限公司 一种米铂的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR898614A (fr) 1942-10-15 1945-04-27 Auergesellschaft Ag Verre à lunettes contenant du néodyme
US4206226A (en) * 1977-08-29 1980-06-03 The United States Of America As Represented By The Department Of Health, Education And Welfare Use of 4-carboxy-phthalato-(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof in alleviating L1210 murine leukemia
SE447385B (sv) * 1977-10-19 1986-11-10 Johnson Matthey Co Ltd Cis-koordinationsforeningar av platina
SE447902B (sv) * 1977-10-19 1986-12-22 Johnson Matthey Co Ltd Cis-koordinationsforening av platina och komposition innehallande foreningen
US4203912A (en) * 1977-10-19 1980-05-20 Johnson, Matthey & Co., Limited Compositions containing platinum
US4284579A (en) * 1979-07-17 1981-08-18 The United States Of America As Represented By The Of The Department Of Health & Human Services (N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
JPS56154493A (en) * 1980-04-30 1981-11-30 Shionogi & Co Ltd Novel platinum complex
JPS5716895A (en) * 1980-07-05 1982-01-28 Otsuka Chem Co Ltd Platinum 2 complex and antitumor agent containing the same as active principle
JPS57123198A (en) * 1981-01-23 1982-07-31 Shionogi & Co Ltd Novel platinum complex
EP0113508A1 (en) 1982-11-04 1984-07-18 Inco Research & Development Center, Inc. Hydrophobic platinum compounds and their preparation
EP0130482B1 (en) * 1983-06-20 1988-12-28 Research Corporation Diaminocyclohexane platinum complexes, process for preparing same and pharmaceutical compositions containing same
EP0136012B1 (en) 1983-08-05 1989-04-19 Yoshinori Kidani Cytostatic platinum complexes
US5041581A (en) 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes

Also Published As

Publication number Publication date
US6613799B1 (en) 2003-09-02
AU587235B2 (en) 1989-08-10
EP0193936A1 (en) 1986-09-10
JPS6296A (ja) 1987-01-06
ES8704505A1 (es) 1987-04-01
EP0193936B1 (en) 1989-05-31
AU5435886A (en) 1986-09-11
ES552722A0 (es) 1987-04-01
JPH0576954B2 (enExample) 1993-10-25
CA1261864A (en) 1989-09-26
DE3663667D1 (en) 1989-07-06

Similar Documents

Publication Publication Date Title
ATE43605T1 (de) Lipoloeslicher platin(ii)-komplex und dessen herstellung.
ATE168373T1 (de) Benzofuranyl- und thiophenylalkancarbonsäurederivate
DE68911742D1 (de) Substituierte flavonoide Verbindungen, ihre Salze, ihre Herstellung und die enthaltende Arnzeizusammensetzungen.
MXPA04007068A (es) Derivados de almidon, conjugados de almidon con sustancia activa, metodo para su produccion y su uso como medicamentos.
EP0194161A3 (en) Cyclopentaûd¨pyrimidine derivatives, their preparation and use
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DE3877386D1 (de) Antikrebsverbindungen.
GB1359542A (en) Diglycidyl derivatives of n-heterocyclic compounds processes for their production and the use thereof
ES431497A1 (es) Procedimiento para preparar un derivado de s-triazol (1,5- a) piridina.
EP0281463A3 (en) Platinum complex, process for its preparation and pharmaceutical composition including such a complex
ATE3769T1 (de) 1-imidazol-2-yliden-3-thienyl-harnstoffderivate verfahren zu deren herstellung und pharmazeutische zusammensetzungen.
ATE61360T1 (de) Antioxidierend wirkende verbindungen, ihre herstellung und ihre verwendung.
ATE69605T1 (de) Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide.
GB1394619A (en) Imides
ATE64740T1 (de) Platin enthaltender cytostatischer wirkstoff.
EP0299076A4 (en) 5-hydroxyindole-3-carboxamide compound and medicinal use thereof
GB1082444A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
DE3678086D1 (de) Rhizoxinderivate, ihre herstellung und pharmazeutische verwendung.
ES8307791A1 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
DE3887612D1 (de) Salicylate, ihre Salze, diese enthaltende pharmazeutische Kompositionen und ihr Herstellungsverfahren.
DE1668887C3 (de) Ca-SaIz der 1,2 -Dithia-cyclopentan - 3- valerian Säure (Thioctsäure)
IT1204960B (it) Composti dotati di attivita' antiallergica
JPS646290A (en) Fat-soluble platinum ii complex and production thereof
ATE63544T1 (de) 4-cyanopiperidine-derivate, herstellung und anwendung.
GB1333524A (en) Penicilloic acid derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee